Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

MSD spends $6.7bn to buy Terns Pharmaceuticals in cancer pipeline reinforcement

Terns’ lead candidate has demonstrated “unprecedented data” in chronic myeloid leukaemia, according to analysts.

Latest news

The Most Favored Nation Policy: early insights into Europe’s response

GlobalData analysed the product launch and withdrawal trends using its Price Intelligence (POLI) database, comparing activity in the ten months before and after the MFN policy’s announcement.

FDA opens door to feedback on ‘unclear’ national priority voucher pathway

A total of 18 vouchers have been issued via the framework despite a lack of clarity on the awarding process.

UCB banks on Georgia for $2bn biologics manufacturing facility

This new facility, which will reside in the same state as UCB’s US HQ in Smyrna, will produce biologics from the company’s portfolio and pipeline.

Daiichi Sankyo and Tempus AI collaborate on ADC clinical development

The partnership will combine Daiichi Sankyo’s clinical trial and preclinical research data with Tempus’ real-world data.

Cognito Therapeutics and Ochsner partner for new brain health approaches

The Collaboratory leverages the expertise of Ochsner Health’s Neuroscience Institute.

Improving early detection and treatment of liver cancer

While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating immunotherapy-based strategies in this setting.